Monday, September 2, 2013

Novartis heart failure drug effective across patient groups

By Ben Hirschler AMSTERDAM (Reuters) - An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug, serelaxin, which is a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is viewed as an important medicine in the Swiss drugmaker's developmental pipeline. Analysts at Jefferies expect the drug to generate peak sales of $1.5 billion a year. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/novartis-heart-failure-drug-effective-across-patient-groups-120039772--finance.html

No comments:

Post a Comment